ArticleScientific reports2025
Low molecular weight fucoidan differentiation media enhances quality and extents shelf life of 3D human skin model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In vitro three-dimensional artificial human skin models (3D-HSMs) have revolutionized research in drug testing, disease modeling, and cosmetic evaluations. However, preserving the shelf-life of 3D-HSM during extended culture remains a challenge. Our previous study uncovered the anti-proliferative effect of fibroblasts exposed to low-molecular-weight fucoidan (LMW-F) at a lower concentration. Based on this study, we developed growth and differentiation media with LMW-F to extend 3D-HSM shelf-life. Two specifically designed media types supplemented with LMW-F components were formulated: (1) growth media (DFR-GM) consisting of DMEM (low glucose), Ham's F-12 K, and RPMI 1640 in a precise 2:2:1 ratio, with (LMW-F-DFR-GM) or without LMW-F (con-DFR-GM), and (2) differentiation media (DFR-DM) consisting of the same composition of DFR-GM with the addition of CaCl2, with (LMW-F-DFR-DM) or without LMW-F (con-DFR-DM). Human cell-based 3D-full-thickness HSE model (3D-FT-HSEM) was incubated with these media for 28 days. In comparison to the control group, the 3D-FT-HSEMs cultured in LMW-F supplemented medium showed a 47% reduction in diameter and retained 25% of their thickness (compared to a 94% reduction and complete degradation in the control group), along with enhanced expression of Ki67 proliferation marker (by approximately 20% at day 21) and reduced cell death. Overall, the present study provides valuable insights into enhancing the quality and extending the shelf-life of 3D-FT-HSEMs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.